Low coverage of influenza vaccination among Chinese children aged 12-23 months: Prevalence and associated factors-Reference-Cited by-同舟云学术

Low coverage of influenza vaccination among Chinese children aged 12-23 months: Prevalence and associated factors

Published:2018-10-10 Issue:10 Volume:13 Page:e0205561
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lau Joseph T. F.^ORCID,Ng Catalina S. M.,Wu Anise M. S.,Ma Yee Ling,Lau Mason M. C.

Funder

Research Fund for the Control of Infectious Diseases, Food and Health Bureau, HKSAR

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection;K Ampofo;Pediatrics,2006

2. Centers for Disease Control and Prevention. Children, the flu, and the flu vaccine. 2017. Available from: https://www.cdc.gov/flu/protect/children.htm

3. Vaccines against influenza WHO position paper–November 2012;Weekly Epidemiological Records,2012

4. Recommendations of the Advisory Committee on Immunization Practices (ACIP);Morb Mortal Wkly Rep,2009

5. Influenza vaccination coverage among children aged 6–23 months—United States, 2005–06 influenza season;Morb Mortal Wkly Rep,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Influencing Childhood Influenza Vaccination: A Systematic Review;Vaccines;2024-02-23

2. The epidemiological trends of 45 national notifiable infectious diseases in China: An analysis of national surveillance data from 2013 to 2022;2024-01-22

3. Coverage and impact of influenza vaccination among children in Minhang District, China, 2013–2020;Frontiers in Public Health;2023-08-30

4. Predictors of Influenza Vaccination among Chinese Middle School Students Based on the Health Belief Model: A Mixed-Methods Study;Vaccines;2022-10-26

5. Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study;Human Vaccines & Immunotherapeutics;2021-09-02